Skip to main content
For research use only — not for human consumption
PR-39 original Regena research vial

Antimicrobial · Proline-rich, porcine cathelicidin-derived antimicrobial peptide

PR-39

Also known as Proline–arginine-rich peptide 39

A proline- and arginine-rich porcine peptide studied for bacterial intracellular activity and interactions with cellular proteins.

Length
39 amino acids
Half-life
Not well characterised
Mechanism
PR-39 can enter susceptible bacteria and interfere with intracellular processes, including protein and DNA synthesis, without requiring extensive membrane lysis. In separate cell and biochemical models, interactions with SH3-domain proteins and modulation of proteasome-associated processes have also been reported; no single receptor explains all observed activities.
Studied in
Bacterial uptake and macromolecular-synthesis assays, SH3-domain binding experiments and cultured-cell proteasome studies investigate its distinct intracellular activities.

About PR-39

PR-39 was originally isolated from porcine small intestine and was subsequently identified in porcine neutrophils as a cathelicidin-derived peptide. Its name reflects its 39-residue length and unusually high content of proline and arginine. Unlike the cysteine-rich protegrins, PR-39 contains no disulphide-bonded β-hairpin scaffold. Its proline-rich sequence instead supports an extended structural character and protein-interaction motifs, making it a distinct research tool within the broader group of innate-defence peptides.

Bacterial studies distinguish PR-39 from strongly membrane-lytic peptides by examining cellular uptake and inhibition of macromolecular synthesis. Uptake determinants, including SbmA in susceptible bacterial systems, can influence experimental sensitivity. Separate biochemical and cultured-cell studies examine binding to SH3-domain-containing proteins such as p47phox, as well as effects on proteasome-associated protein turnover. These findings represent different experimental contexts and should not be collapsed into one universal mechanism or assumed to share an identical molecular target.

Laboratory notes

  • For research use only; confirm that material is full-length PR-39 rather than an N-terminal fragment used in some mechanistic studies.
  • Include uptake-deficient bacterial controls where available when testing whether activity depends on intracellular access.
  • For protein-interaction assays, include unrelated proline-rich peptide controls and assess whether labels alter binding or uptake.

Storage and reconstitution basics: storage guide.

Questions about PR-39

Does PR-39 require disulphide folding?

No. PR-39 lacks cysteine residues and therefore does not require intramolecular disulphide formation. Its structural behaviour differs from that of β-hairpin peptides such as protegrins.

Why is SbmA relevant to bacterial experiments?

SbmA can facilitate entry of proline-rich antimicrobial peptides in susceptible bacteria. Comparing appropriate uptake-proficient and uptake-deficient strains helps assess the contribution of intracellular access.

Is inhibition of macromolecular synthesis proof of a direct molecular target?

No. Reduced protein or DNA synthesis is a functional readout and may include downstream effects. Direct target assignment requires additional binding, biochemical or genetic evidence.

Is PR-39 for human use?

No. It is supplied strictly for in-vitro laboratory research and is not for human or animal consumption.

Related research peptides

All products are sold for laboratory research use only. Not for human consumption, not a medicine, not for diagnosing, treating or preventing any condition.